In June 2007, Bowel Cancer Australia announced plans to expand Australia’s capacity for bowel cancer and digestive health research through the establishment of an inaugural Chair in Bowel Cancer Research.
Bowel Cancer Australia intends to recruit a gastroenterologist with a world class record in research and/or clinical practice. The position will help to attract and retain some of the best and brightest clinical scientists, researchers, physicians and surgeons from around the world to work with the Chair.
To be located on the Royal North Shore Hospital campus, Sydney, the Chair will build upon existing research expertise in the areas of bowel cancer, liver disease, Crohn’s disease, irritable bowel syndrome, gut motility and bowel dysfunction in spinal cord injury.
Valuable research bench space has already been secured in the recently completed $95 million purpose built state-of-the-art research and education facility.
The Chair will provide exciting new growth opportunities in bowel cancer and digestive health research and education, benefiting the Australian community.
The initiative has received a $1million funding commitment from Patron, Mr Richard Penn.
In recognition of the Penn family’s generous commitment, the Chair is to be named the Lawrence Penn Chair in Bowel Cancer Research after Mr Penn’s father, a bowel cancer survivor.
Bowel Cancer Australia will further seek to raise additional funds that will endow and secure this inaugural post in perpetuity.
Donations and gifts made to the Chair in Bowel Cancer Research will be permanently invested, with only the income spent each year to support the salary of the Chair holder as well as the appointee’s related research and educational activities.